Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroids (Q33598604)

28 July 2017

title

Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroids (English)

1 reference

28 July 2017

1 reference

Timothy I Richardson

1

1 reference

28 July 2017

Christian A Clarke

2

1 reference

28 July 2017

Kuo-Long Yu

3

1 reference

28 July 2017

Ying K Yee

4

1 reference

28 July 2017

Thomas J Bleisch

5

1 reference

28 July 2017

Jose E Lopez

6

1 reference

28 July 2017

Scott A Jones

7

1 reference

28 July 2017

Norman E Hughes

8

1 reference

28 July 2017

Brian S Muehl

9

1 reference

28 July 2017

Charles W Lugar

10

1 reference

28 July 2017

Terry L Moore

11

1 reference

28 July 2017

Pamela K Shetler

12

1 reference

28 July 2017

Richard W Zink

13

1 reference

28 July 2017

John J Osborne

14

1 reference

28 July 2017

Chahrzad Montrose-Rafizadeh

15

1 reference

28 July 2017

Nita Patel

16

1 reference

28 July 2017

Andrew G Geiser

17

1 reference

28 July 2017

Rachelle J Sells Galvin

18

1 reference

28 July 2017

Jeffrey A Dodge

19

1 reference

28 July 2017

publication date

9 December 2010

1 reference

ACS Medicinal Chemistry Letters

28 July 2017

published in

1 reference

28 July 2017

volume

2

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

148-153

1 reference

Modern management of uterine fibroids

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

Etiology, symptomatology, and diagnosis of uterine myomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

A benefit-risk assessment of medical treatment for uterine leiomyomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

Traditional surgical approaches to uterine fibroids: abdominal myomectomy and hysterectomy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

Introduction: the epidemiology of uterine leiomyomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

Recurrence of fibroids after myomectomy: a transvaginal ultrasonographic study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

Uterine leiomyomata: etiology, symptomatology, and management.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

(S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

Changes in rates of hysterectomy and uterine conserving procedures for treatment of uterine leiomyoma

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safety

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

Low molecular weight indole fragments as IMPDH inhibitors

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

Biomedicine. Defining the "S" in SERMs

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4017981

30 October 2018

The assay of progestin

1 reference

12 December 2020

A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri

1 reference

12 December 2020

The frequency of uterine leiomyomas

1 reference

12 December 2020

A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata

1 reference

12 December 2020

Response of fibromyomas to a progestin*

1 reference

12 December 2020

Selective progesterone receptor modulators 2: use in reproductive medicine

1 reference

12 December 2020

Air-stable trialkylphosphonium salts: simple, practical, and versatile replacements for air-sensitive trialkylphosphines. Applications in stoichiometric and catalytic processes

1 reference

12 December 2020

Identifiers

DOI

10.1021/ML100220B

1 reference

28 July 2017

1 reference

28 July 2017

1 reference